Neuroene Therapeutics

About:

Neuroene Therapeutics is a startup biotechnology company.

Website: https://www.neuroenetherapeutics.com

Twitter/X: neuroene

Top Investors: National Institutes of Health, Small Business Innovation Research, PipelBiz.com

Description:

Neuroene Therapeutics is a startup biotechnology company developing novel Vitamin K-based therapeutics for neurological disorders such as epilepsy. The company originated from collaborative research between Medical University of South Carolina investigators C. James Chou, Ph.D., and Sherine Chan, Ph.D., who cofounded and continue to lead Neuroene Therapeutics.

Total Funding Amount:

$2.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Mount Pleasant, South Carolina, United States

Founded Date:

2015-01-01

Contact Email:

neuroenetherapeutics(AT)gmail.com

Founders:

C. James Chou, Richard Himes, Sherine Chan

Number of Employees:

11-50

Last Funding Date:

2019-08-15

IPO Status:

Private

Industries: